Discover 921 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 921
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
for
Plaque Psoriasis
Location: Portland OR, Warrenton OR, Mill Creek WA, Surrey,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07474792
Phase2, Recruiting
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
for
Palmoplantar Pustulosis
Location: Portland OR, Surrey, Calgary, Edmonton,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT07013201
Phase2, Recruiting
Sedentary Behavior, Cardiovascular Function, and Sleep
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Portland OR, Seattle WA, Sacramento CA,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
for
Alagille Syndrome,
Location: Portland OR, Salt Lake City UT, Los Angeles CA,
Sponsor: Mirum Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT06193928
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Location: Portland OR, Calgary, Los Angeles CA, Loma Linda CA,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 0+
Code: NCT03394365
Phase3, Recruiting
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
for
IC-MPGN
Location: Portland OR, San Francisco CA, Salt Lake City UT,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 60
Code: NCT05755386
Phase3, Recruiting
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
for
Osteogenesis Imperfecta (OI)
Location: Portland OR, Phoenix AZ, Albuquerque NM,
Sponsor: Angitia Incorporated Limited
Sex: All
Age: 18 - 70+
Code: NCT07062588
Phase2, Recruiting
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
for
IgA Nephropathy
Location: Portland OR, San Francisco CA, Stanford CA, Fresno CA,
Sponsor: Calliditas Therapeutics AB
Sex: All
Age: 18+
Code: NCT06712407
Recruiting
New
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence